002653 On Other Exchanges
Symbol
Exchange
Shenzhen

haisco pharmaceutical grou-a (002653) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HAISCO PHARMACEUTICAL GROU-A (002653)
\

Related News

No related news articles were found.

haisco pharmaceutical grou-a (002653) Related Businessweek News

No Related Businessweek News Found

haisco pharmaceutical grou-a (002653) Details

Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. The company offers capsules, tablets, granules, and bulk drugs in the fields of cardiovascular, anti-infection, digestive system, nervous and mental system, hepatopathy, diabetes mellitus, etc., as well as liver disease, parenteral nutrition, first-aid, antibiotics, anesthesia, and tumor adjuvant. It is also developing nalmefene hydrochloride injection, dolasetron mesylate injection, cefodizime sodium for injection, hydroxyethyl starch and sodium chloride injection, medium and long chain fat emulsion injection, and compound amino acids injection. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Chengdu, China.

2,211 Employees
Last Reported Date: 03/27/19
Founded in 2000

haisco pharmaceutical grou-a (002653) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

haisco pharmaceutical grou-a
Haisco Pharmaceutical Group Co., Ltd. Announces A Shares 2018 Final Distribution Plan to Be Implemented, Payable on May 15, 2019

Haisco Pharmaceutical Group Co., Ltd. announced tax included A shares 2018 final distribution of CNY 1.90000000 per ten shares plan to be implemented, payable on May 15, 2019 with record date of May 14,2019 and ex- date of May 15, 2019.

Haisco Pharmaceutical Group Co., Ltd., Special/Extraordinary Shareholders Meeting, May 15, 2019

Haisco Pharmaceutical Group Co., Ltd., Special/Extraordinary Shareholders Meeting, May 15, 2019, at 15:00 China Standard Time. Agenda: To consider the first phase restricted stock incentive plan (draft) and its summary; to consider appraisal management measures for the implementation of the first phase restricted stock incentive plan; and to consider authorization to the board to handle matters regarding the first phase restricted stock incentive plan.

Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019

Haisco Pharmaceutical Group Co., Ltd. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was CNY 838.997 million compared to CNY 478.056 million a year ago. Operating income was CNY 56.849 million compared to CNY 69.745 million a year ago. Net income was CNY 49.822 million compared to CNY 59.765 million a year ago. Basic earnings per share from continuing operations was CNY 0.05 compared to CNY 0.06 a year ago.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

002653 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002653.
View Industry Companies
 

Industry Analysis

002653

Industry Average

Valuation 002653 Industry Range
Price/Earnings 45.0x
Price/Sales 3.6x
Price/Book 7.0x
Price/Cash Flow 45.2x
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact HAISCO PHARMACEUTICAL GROU-A, please visit www.haisco.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.